发明公开
EP1742939A2 NEUE ALKIN-VERBINDUNGEN MIT MCH-ANTAGONISTISCHER WIRKUNG UND DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL
审中-公开
新ALKIN CONNECTIONS MCH拮抗作用及药物含有它们的
- 专利标题： NEUE ALKIN-VERBINDUNGEN MIT MCH-ANTAGONISTISCHER WIRKUNG UND DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL
- 专利标题（英）： Novel alkyne compounds exhibiting an mch antagonistic effect and drugs containing said compounds
- 专利标题（中）： 新ALKIN CONNECTIONS MCH拮抗作用及药物含有它们的
-
申请号： EP05729108.0申请日： 2005-04-08
-
公开(公告)号： EP1742939A2公开(公告)日： 2007-01-17
- 发明人: STENKAMP, Dirk , MUELLER, Stephan Georg , LUSTENBERGER, Philipp , LEHMANN-LINTZ, Thorsten , ROTH, Gerald Jürgen , RUDOLF, Klaus , SCHINDLER, Marcus , THOMAS, Leo , LOTZ, Ralf R. H.
- 申请人： Boehringer Ingelheim International GmbH , Boehringer Ingelheim Pharma GmbH & Co. KG
- 申请人地址： Binger Strasse 173 55216 Ingelheim DE
- 专利权人： Boehringer Ingelheim International GmbH,Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人： Boehringer Ingelheim International GmbH,Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人地址： Binger Strasse 173 55216 Ingelheim DE
- 代理机构： Hammann, Heinz
- 优先权： DE102004017933 20040414
- 国际公布： WO2005100285 20051027
- 主分类号： C07D405/14
- IPC分类号： C07D405/14 ; A61K31/4433 ; A61P3/04
摘要：
The invention relates to an alkyne compound of general formula (I) in which A, B, W, X, Y, Z, R1 and R2 groups and residuals have the meanings given in claim 1. Drugs containing at least one type of inventive alkyne are also disclosed. The inventive drugs exhibiting an MCH-receptor antagonistic activity are suitable for treating metabolic disturbances and/or eating disorders, in particular adiposity, bulimia, anorexia, hyperphagia and diabetes.
信息查询
